Abivax S.A.(ABVX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ABVX Abivax S.A.

Closed 12-05 16:00:00 EST

114.51

+3.87

+3.50%

盘后117.92

+3.41+2.98%

19:56 EST

High115.12	Low109.10	Vol1.30M
Open109.75	D1 Closing110.64	Amplitude5.44%
Mkt Cap8.92B	Tradable Cap4.88B	Total Shares77.90M
T/O145.88M	T/O Rate3.04%	Tradable Shares42.66M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ABVX","market":"US","secType":"STK","nameCN":"Abivax S.A.","latestPrice":114.51,"timestamp":1764968400000,"preClose":110.64,"halted":0,"volume":1297146,"hourTrading":{"tag":"盘后","latestPrice":117.92,"preClose":114.51,"latestTime":"19:56 EST","volume":15868,"amount":1849096.0873,"timestamp":1764982611530},"delay":0,"floatShares":42655700,"shares":77903300,"eps":-3.625474,"marketStatus":"Closed","change":3.87,"latestTime":"12-05 16:00:00 EST","open":109.75,"high":115.12,"low":109.1,"amount":145879451.85156,"amplitude":0.054411,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.625474,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":5,"adr":0,"adrRate":1,"listingDate":1697774400000,"exchange":"NASDAQ","adjPreClose":110.64,"preHourTrading":{"tag":"盘前","latestPrice":109.63,"preClose":110.64,"latestTime":"09:29 EST","volume":11864,"amount":1299598.5764,"timestamp":1764944971055},"postHourTrading":{"tag":"盘后","latestPrice":117.92,"preClose":114.51,"latestTime":"19:56 EST","volume":15868,"amount":1849096.0873,"timestamp":1764982611530},"volumeRatio":0.896347,"impliedVol":1.2377,"impliedVolPercentile":0.9636},"requestUrl":"/m/hq/s/ABVX","defaultTab":"news","newsList":[{"id":"1149270572","title":"After Surging 1300%, Abivax's (ABVX.US) \"Bullish Narrative\" May Not Be Over","url":"https://stock-news.laohu8.com/highlight/detail?id=1149270572","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149270572?lang=en_us&edition=fundamental","pubTime":"2025-12-04 15:44","pubTimestamp":1764834269,"startTime":"0","endTime":"0","summary":"French biotech firm Abivax (ABVX.US) started the year with a market cap below $500 million. Following a meteoric rise, its valuation now exceeds $8 billion, with some analysts suggesting further...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2584957221","title":"6 Healthcare Stocks With Strong Upward Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2584957221","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584957221?lang=en_us&edition=fundamental","pubTime":"2025-11-19 01:59","pubTimestamp":1763488740,"startTime":"0","endTime":"0","summary":"Out with the old , in with the new . After several volatile weeks, it appears a full-fledged rotation has begun with investors fleeing previously high-flying tech winners in favor of underserved healthcare stocks.The rotation has technical and fundamental tailwinds too, as healthcare earnings have been strong and several stocks are breaking out into new uptrends.Today, we'll look at six stocks in the healthcare sector that have been surging higher for a variety of reasons and score well on Benzinga’s Momentum rankings.Benzinga Edge helps you stay ahead with real-time data, stock rankings, and exclusive analyst insights. Spot opportunity before the headlines hit and secure full access for 65% off.Now let's jump to the biotech sector with Abivax , a French pharmaceutical developer focused on chronic inflammatory diseases. The compa","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/11/18/Healthcare-stocks.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/11/18/Healthcare-stocks.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/25/11/48931956/6-healthcare-stocks-with-strong-upward-momentum","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/25/11/48931956/6-healthcare-stocks-with-strong-upward-momentum","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU1267930490.SGD","LU1880398471.USD","BK4121","LU2065171311.SGD","BK4196","GH","LU1571399168.USD","PSQ","LU2065169927.USD","MNQmain","USJW.SI","BK4175","HCSG","BK4581","LU0310799852.SGD","LU1880398554.USD","NQmain","XBI","ELAN","BK4588","LU0889566641.SGD","LU0211328371.USD","QLD","BK4551","LU2065170008.USD","TQQQ","LU0154236417.USD","LU1941712348.USD","QID","BK4139","NVIW.SI","USAW.SI","SMA","MEDP","WGS","LABU","BK4137","CAH","XLV","LU0072461881.USD","LU0128525689.USD","TSYW.SI","LU2065171402.SGD","SQQQ",".IXIC","BK4535","LU0310800965.SGD","ABVX","LU0006061336.USD"],"gpt_icon":1},{"id":"2580317753","title":"BTIG Remains a Buy on Abivax SA Sponsored ADR (ABVX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2580317753","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580317753?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:36","pubTimestamp":1762266971,"startTime":"0","endTime":"0","summary":"BTIG analyst Julian Harrison maintained a Buy rating on Abivax SA Sponsored ADR yesterday and set a price target of $120.00. The company’s shares o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/btig-remains-a-buy-on-abivax-sa-sponsored-adr-abvx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/btig-remains-a-buy-on-abivax-sa-sponsored-adr-abvx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AAVXF","BK4139","ABVX"],"gpt_icon":0},{"id":"2580229216","title":"Abivax announces patient-reported outcomes from ABTECT trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2580229216","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580229216?lang=en_us&edition=fundamental","pubTime":"2025-11-04 06:15","pubTimestamp":1762208120,"startTime":"0","endTime":"0","summary":"Abivax (ABVX) announced patient-reported outcomes from its Phase 3 ABTECT 8-week induction trials evaluating obefazimod in adult patients with mode...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abivax-announces-patient-reported-outcomes-from-abtect-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abivax-announces-patient-reported-outcomes-from-abtect-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVX","BK4139"],"gpt_icon":0},{"id":"2575037471","title":"Abivax initiated with an Overweight at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2575037471","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575037471?lang=en_us&edition=fundamental","pubTime":"2025-10-13 17:25","pubTimestamp":1760347510,"startTime":"0","endTime":"0","summary":"Barclays analyst Etzer Darout initiated coverage of Abivax (ABVX) with an Overweight rating and $142 price target The firm launched coverage of eig...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abivax-initiated-with-an-overweight-at-barclays-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abivax-initiated-with-an-overweight-at-barclays-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVX","BK4139"],"gpt_icon":0},{"id":"2574127284","title":"Abivax price target raised, named a ‘Best Idea’ at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2574127284","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574127284?lang=en_us&edition=fundamental","pubTime":"2025-10-10 18:40","pubTimestamp":1760092848,"startTime":"0","endTime":"0","summary":"Guggenheim raised the firm’s price target on Abivax (ABVX) to $150 from $101 and keeps a Buy rating on the shares, which have also been designated ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abivax-price-target-raised-named-a-best-idea-at-guggenheim-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abivax-price-target-raised-named-a-best-idea-at-guggenheim-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVX","BK4139"],"gpt_icon":0},{"id":"2573416943","title":"Abivax SA Sponsored ADR (ABVX) Receives a Rating Update from a Top Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2573416943","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573416943?lang=en_us&edition=fundamental","pubTime":"2025-10-08 15:55","pubTimestamp":1759910112,"startTime":"0","endTime":"0","summary":"In a report released on October 6, Thomas Smith from Leerink Partners reiterated a Buy rating on Abivax SA Sponsored ADR. The company’s shares clos...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/abivax-sa-sponsored-adr-abvx-receives-a-rating-update-from-a-top-analyst-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/abivax-sa-sponsored-adr-abvx-receives-a-rating-update-from-a-top-analyst-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AAVXF","ABVX"],"gpt_icon":0},{"id":"2573951300","title":"Abivax Sa : Leerink Partners Raises Target Price to $115 From $104","url":"https://stock-news.laohu8.com/highlight/detail?id=2573951300","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573951300?lang=en_us&edition=fundamental","pubTime":"2025-10-07 18:47","pubTimestamp":1759834058,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nFWN3VO1RA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2573934609","title":"Abivax Sa : Btig Raises Target Price to $120 From $112","url":"https://stock-news.laohu8.com/highlight/detail?id=2573934609","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573934609?lang=en_us&edition=fundamental","pubTime":"2025-10-07 13:55","pubTimestamp":1759816531,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nFWN3VO0W6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABVX","BK4139"],"gpt_icon":0},{"id":"2573607036","title":"Abivax price target raised to $120 from $112 at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2573607036","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573607036?lang=en_us&edition=fundamental","pubTime":"2025-10-07 03:00","pubTimestamp":1759777223,"startTime":"0","endTime":"0","summary":"BTIG raised the firm’s price target on Abivax (ABVX) to $120 from $112 and keeps a Buy rating on the shares. Based on the data from the ABTECT 1 and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abivax-price-target-raised-to-120-from-112-at-btig-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abivax-price-target-raised-to-120-from-112-at-btig-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVX","BK4139"],"gpt_icon":0},{"id":"2573760664","title":"Why Is Abivax Stock Trading Higher On Monday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2573760664","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573760664?lang=en_us&edition=fundamental","pubTime":"2025-10-06 23:05","pubTimestamp":1759763100,"startTime":"0","endTime":"0","summary":"Abivax said Phase 3 trials showed obefazimod improved clinical outcomes in ulcerative colitis, meeting key endpoints with no new safety concerns.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/06/Medical-research.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/06/Medical-research.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/25/10/48046820/why-is-abivax-stock-trading-higher-on-monday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/10/48046820/why-is-abivax-stock-trading-higher-on-monday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2573367779","title":"Sector Update: Health Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2573367779","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573367779?lang=en_us&edition=fundamental","pubTime":"2025-10-06 21:00","pubTimestamp":1759755657,"startTime":"0","endTime":"0","summary":"Health care stocks were edging higher pre-bell Monday, with The Health Care Select Sector SPDR Fund  up 0.1% and the iShares Biotechnology ETF  advancing by 0.2%.Abivax  shares were up more than 7% after the company said results from two clinical trials showed that a 50-milligram daily dose regimen of its potential moderate-to-severely active ulcerative colitis treatment obefazimod met its primary endpoint of clinical remission at week eight.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4581","ABVX","BK4588","BK4585","XLV","IBB","XBI","LABU"],"gpt_icon":0},{"id":"2573677917","title":"Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Amid AMD-OpenAI AI Chip Deal, Rate Cut Hopes","url":"https://stock-news.laohu8.com/highlight/detail?id=2573677917","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573677917?lang=en_us&edition=fundamental","pubTime":"2025-10-06 20:53","pubTimestamp":1759755233,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.3% and the actively traded Invesco QQQ Trust (QQQ) was 0.6% higher in Monday's premarket activity amid the Advanced Micro De","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"efd6669ef4dd75bf3ca8626caaec6f68","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBB","VDC","XLV","VHT.AU","EETH","VIS","FAZ","RTH","AMD.AU","ABVX","UNG","IYK","RTH.AU","XLI","BETH","GFS","SPY","XLY","EXI","FLY","IVV","EQR","CMA","VHT","SOXX","SPY.AU","BITO","IYE","FITB","USO","IYH","XRT","QQQ","AMD","XLK","XLF","SOC.AU","IYJ","XSD","XLE","IYW","XLP","PMR","FAS","SOC","IGM"],"gpt_icon":1},{"id":"2573273776","title":"Abivax Says Potential Ulcerative Colitis Treatment Meets Primary Endpoint in 2 Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2573273776","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573273776?lang=en_us&edition=fundamental","pubTime":"2025-10-06 15:49","pubTimestamp":1759736952,"startTime":"0","endTime":"0","summary":"Abivax  said Sunday that results from two clinical trials showed that a 50 milligram daily dose regimen of its potential moderate-to-severely active ulcerative colitis treatment obefazimod met its primary endpoint of clinical remission at week eight.The company said all key secondary efficacy endpoints were also met in the trials, which enrolled 1,272 patients.In pooled data from the trials, no signals of serious or severe infections or malignancies were observed, the company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ABVX","BK4139"],"gpt_icon":0},{"id":"2573161057","title":"Abivax announces ABTECT 1, ABTECT 2 trials met primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2573161057","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573161057?lang=en_us&edition=fundamental","pubTime":"2025-10-06 01:10","pubTimestamp":1759684212,"startTime":"0","endTime":"0","summary":"Abivax (ABVX) SA announced results from the first of two late-breaking presentations at the United European Gastroenterology, UEG, Meeting in Berli...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abivax-announces-abtect-1-abtect-2-trials-met-primary-endpoint-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abivax-announces-abtect-1-abtect-2-trials-met-primary-endpoint-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVX","BK4139"],"gpt_icon":0},{"id":"2566797503","title":"Abivax Sa : Leerink Partners Raises Target Price to $104 From $74","url":"https://stock-news.laohu8.com/highlight/detail?id=2566797503","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566797503?lang=en_us&edition=fundamental","pubTime":"2025-09-12 19:23","pubTimestamp":1757676220,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nFWN3UZ0KX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABVX","BK4139"],"gpt_icon":0},{"id":"2566658792","title":"Abivax SA reports results for the quarter ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2566658792","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566658792?lang=en_us&edition=fundamental","pubTime":"2025-09-09 07:03","pubTimestamp":1757372615,"startTime":"0","endTime":"0","summary":"Abivax SA reports results for the quarter ended June 30 - Earnings SummaryAbivax SA ABVX.OQ reported a quarterly adjusted loss of 76 cents per share for the quarter ended June 30.  The mean expectatio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nL5N3UV1R3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"gpt_icon":0},{"id":"2565664865","title":"Abivax SA  expected to post a loss of 77 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2565664865","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565664865?lang=en_us&edition=fundamental","pubTime":"2025-09-05 22:02","pubTimestamp":1757080948,"startTime":"0","endTime":"0","summary":"Abivax SA  expected to post a loss of77cents a share - Earnings Preview Abivax SA ABVX.OQ, ABVX.O is expected to  report resultson September 8 for the period ending March 31 2025The Paris Ile-de-franc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250905:nL8N3US0VB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"gpt_icon":0},{"id":"2555506000","title":"Abivax Sa : Piper Sandler Raises Target Price to $112 From $70","url":"https://stock-news.laohu8.com/highlight/detail?id=2555506000","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555506000?lang=en_us&edition=fundamental","pubTime":"2025-07-29 23:20","pubTimestamp":1753802415,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250729:nFWN3TQ1BO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2555362460","title":"Abivax Closes $747.5 Million Offering of American Depositary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2555362460","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555362460?lang=en_us&edition=fundamental","pubTime":"2025-07-29 17:00","pubTimestamp":1753779603,"startTime":"0","endTime":"0","summary":"Abivax SA  said late Monday it closed an offering with gross proceeds of about $747.5 million, securing a 12-month cash runway following a planned submission of a new drug application for ulcerative colitis.Each American depositary share in the 11.7 million offering represents one ordinary share.The company expects the net proceeds, together with the cash and cash equivalents on its balance sheet, to finance its operations until Q4 2027.The planned new drug application assumes the company will achieve positive results from its phase 3 maintenance trial of ulcerative colitis.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4117","BK4107","AFG","BK4139","ABVX"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.abivax.com","stockEarnings":[{"period":"1week","weight":-0.1197},{"period":"1month","weight":0.1217},{"period":"3month","weight":0.2568},{"period":"6month","weight":12.5092},{"period":"1year","weight":11.4454},{"period":"ytd","weight":14.1148}],"compareEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":0.0136},{"period":"3month","weight":0.0574},{"period":"6month","weight":0.1423},{"period":"1year","weight":0.1263},{"period":"ytd","weight":0.1677}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.","exchange":"NASDAQ","name":"Abivax S.A.","nameEN":"Abivax S.A."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Abivax S.A.(ABVX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Abivax S.A.(ABVX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Abivax S.A.,ABVX,Abivax S.A.股票,Abivax S.A.股票老虎,Abivax S.A.股票老虎国际,Abivax S.A.行情,Abivax S.A.股票行情,Abivax S.A.股价,Abivax S.A.股市,Abivax S.A.股票价格,Abivax S.A.股票交易,Abivax S.A.股票购买,Abivax S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Abivax S.A.(ABVX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Abivax S.A.(ABVX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction